Rashed Dewan
Director of Finance/CFO en PROFOUND MEDICAL CORP. .
Fortuna: 202 562 $ al 31/03/2024
Perfil
Rashed Dewan is currently working as the Chief Financial Officer at Profound Medical Corp.
He started this position in 2022.
Previously, he worked as a Controller at Profound Medical, Inc. Mr. Dewan completed his undergraduate degree at the University of Southern California.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
PROFOUND MEDICAL CORP
0.10% | 15/08/2023 | 23 747 ( 0.10% ) | 202 562 $ | 31/03/2024 |
Cargos activos de Rashed Dewan
Empresas | Cargo | Inicio |
---|---|---|
PROFOUND MEDICAL CORP. | Director of Finance/CFO | 03/03/2022 |
Antiguos cargos conocidos de Rashed Dewan.
Empresas | Cargo | Fin |
---|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | - |
Formación de Rashed Dewan.
University of Southern California | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
PROFOUND MEDICAL CORP. | Health Technology |
Empresas privadas | 1 |
---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Rashed Dewan